C. Griffiths

Five‐year maintenance of clinical response and health‐related quality of life improvements in patients with moderate‐to‐severe psoriasis treated with guselkumab: results from VOYAGE 1 and VOYAGE 2 *

A. Armstrong, C. Griffiths, K. Reich, 2021, The British journal of dermatology.

Implementing well‐being in the management of psoriasis: An expert recommendation

A. Zink, U. Mrowietz, Rachel Sommer, 2023, Journal of the European Academy of Dermatology and Venereology : JEADV.

Retinoids in the treatment of photoageing: A histological study of topical retinoid efficacy in black skin.

A. Langton, P. Halai, R. Wang, 2024, Journal of the European Academy of Dermatology and Venereology : JEADV.

Tree-Based Machine Learning to Identify Predictors of Psoriasis Incidence at the Neighborhood Level: A Populational Study from Quebec, Canada.

I. Pivneva, E. Netchiporouk, A. Muntyanu, 2024, American journal of clinical dermatology.

Comparison of Drug Discontinuation, Effectiveness, and Safety Between Clinical Trial Eligible and Ineligible Patients in BADBIR

A. Burden, C. Griffiths, M. Lunt, 2018, JAMA dermatology.